The Patent Finder

BioMarker Pharmaceuticals, Inc.

Also on record
Records under this name other than patents BioMarker Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to BioMarker Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,016,476Nutrient Combinations for Affecting an Aging Process
Lapsed on the fee record
Ended Jul 10, 2026 · High confidence
Lapsed on the fee recordEnded Jul 10, 2026High confidence
US 8,436,224Methods for testing for caloric restriction (CR) mimetics
Lapsed on the fee record
Ended May 7, 2025 · USPTO record
Lapsed on the fee recordEnded May 7, 2025USPTO record
US 8,403,844Methods for interventions
Lapsed on the fee record
Ended Mar 26, 2025 · USPTO record
Lapsed on the fee recordEnded Mar 26, 2025USPTO record
US 9,138,453Nutrient Combinations for Affecting an Aging Process
Lapsed on the fee record
Ended Sep 22, 2023 · High confidence
Lapsed on the fee recordEnded Sep 22, 2023High confidence
US 7,960,605Methods for testing for caloric restriction (CR) mimetics
Lapsed on the fee record
Ended Jun 14, 2023 · USPTO record
Lapsed on the fee recordEnded Jun 14, 2023USPTO record
US 8,692,051Methods for testing for caloric restriction (CR) mimetics
Lapsed on the fee record
Ended Apr 8, 2022 · USPTO record
Lapsed on the fee recordEnded Apr 8, 2022USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited